Developer docs
API playgroundTry for free, no card

Search company profiles

Goldcrest Capital

Full company profile

uuid00002eg

Namestring
Goldcrest Capital
Legal namestring
Goldcrest Capital
Websiteurl
goldcrest.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Goldcrest Capital is a Dallas-based venture capital fund founded in 2016 that invests in private technology companies across the United States and, selectively, Latin America. The firm operates with a lean team of 1-10 employees led by co-founder and managing director Daniel Friedland, and has publicly disclosed eight investments between July 2025 and June 2026 spanning AI infrastructure, applied AI, senior care technology, biotechnology, cybersecurity, insurtech, and energy-to-compute infrastructure.

The fund participates across the full early-stage spectrum, from seed through Series D, using both lead and co-investor postures. Notable lead positions include Unblock's $13.5M funding (Argentine gas-to-compute data centers), Junevity's $20M seed expansion (siRNA therapeutics), and a co-lead of Northslope's $22M Series A alongside Friends & Family Capital. Goldcrest also participates in larger rounds such as Peregrine Technologies' $250M Series D at a $6.8B valuation and Sage Health's $65M Series C led by Goldman Sachs Alternatives, suggesting meaningful reserve capacity for follow-on within a focused portfolio.

As a venture capital vehicle, Goldcrest generates returns through equity ownership and, by industry convention, earns management fees on committed capital plus carried interest on realizations. The firm markets itself through a corporate website (goldcrest.com), an investor portal hosted on fundpanel.io, and a brand assets portal for portfolio companies and press. No AUM, fund vintage, or revenue figures are disclosed, and the provided financial dataset contains figures that are implausible for a sponsor of this size and are not relied upon in this analysis.

Short descriptiontext

Goldcrest Capital is a Dallas-based venture capital fund founded in 2016 that invests in private technology companies across AI, healthcare, biotech, cybersecurity, insurtech, and energy, deploying capital from seed through Series D as lead, co-lead, and participating investor.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDallas, United States
HQ citystring
Dallas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
venture capital, private equity investing, growth capital, technology investments, early-stage funding
Industry1 code
1Late-Stage Venture Capital (Series C+)
CodeFSANAAACPrimaryYes
NAICS code2 codes
  • Other Investment Pools and Funds5259
  • Other Financial Vehicles525990
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles1 record
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Goldcrest Capital is a venture capital fund that invests in private technology companies across multiple stages from seed to Series D. The firm provides equity capital, strategic guidance, and network access to portfolio companies, participating as both lead and co-investor in funding rounds alongside other VC firms. Investments span AI, healthcare technology, cybersecurity, biotechnology, and energy sectors.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Goldcrest Capital is a venture capital fund that invests in private technology companies. As an investment firm, it does not offer products or services in the traditional sense. The company participates in funding rounds for technology startups across various sectors including AI, healthcare technology, cybersecurity, and enterprise software.

Product and service1 record
1Goldcrest Capital Venture Fund
CategoryVenture Capital Fund
Description

Equity capital fund that invests in private technology companies across stages from seed to Series D, spanning sectors such as AI, healthcare technology, cybersecurity, biotechnology, and energy. Targets founders and management teams of private technology startups seeking growth and scaling capital.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Co-invested with Goldcrest in Sage Health's $65M Series C; a much larger late-stage growth VC that Goldcrest partners with on follow-on rounds.

TypeDirect peer
Description

Referenced alongside Goldcrest as part of the same co-investor network; a comparable early-to-mid stage venture investor with similar technology focus.

TypeDirect peer
Description

Co-led Northslope's $22M Series A alongside Goldcrest Capital, indicating comparable stage, check size, and technology focus on applied AI and Palantir-ecosystem companies.

TypeBroad incumbent
Description

Co-investor alongside Goldcrest in Glue's Series A; a larger, more established early-stage SaaS and AI venture firm with broader portfolio and brand recognition.

TypeBroad incumbent
Description

Led QuoteWell's $12M round in which Goldcrest participated; a large multi-stage venture firm that signals deal-quality validation when co-investing with smaller funds like Goldcrest.

TypeDirect peer
Description

Led Fencer's $5.5M seed round in which Goldcrest participated, making it a comparable early-stage cybersecurity investor with similar check sizes and stage focus.

TypeDirect peer
Description

Led Glue's $20M Series A which Goldcrest joined; an early-stage venture firm investing across similar AI, SaaS, and frontier-tech categories with comparable check sizes.

TypeDirect peer
Description

Co-invested with Goldcrest in Glue's Series A; an early-stage tech-focused VC with comparable seed/Series A check sizes and horizontal technology mandate.

TypeDirect peer
Description

Co-led Junevity's expanded $20M seed round with Goldcrest, indicating a similar early-stage biotech and technology investor profile with comparable check sizes.

TypeDirect peer
Description

Referenced as a co-investment partner alongside Goldcrest in the firm's marketing channels, suggesting a comparable early-stage technology VC with similar deal sourcing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment76 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Goldcrest Capital

Venture Capitalgoldcrest.com

Goldcrest Capital is a Dallas-based venture capital fund founded in 2016 that invests in private technology companies across AI, healthcare, biotech, cybersecurity, insurtech, and energy, deploying capital from seed through Series D as lead, co-lead, and participating investor.

What Goldcrest Capital does

Goldcrest Capital is a Dallas-based venture capital fund founded in 2016 that invests in private technology companies across the United States and, selectively, Latin America. The firm operates with a lean team of 1-10 employees led by co-founder and managing director Daniel Friedland, and has publicly disclosed eight investments between July 2025 and June 2026 spanning AI infrastructure, applied AI, senior care technology, biotechnology, cybersecurity, insurtech, and energy-to-compute infrastructure.

The fund participates across the full early-stage spectrum, from seed through Series D, using both lead and co-investor postures. Notable lead positions include Unblock's $13.5M funding (Argentine gas-to-compute data centers), Junevity's $20M seed expansion (siRNA therapeutics), and a co-lead of Northslope's $22M Series A alongside Friends & Family Capital. Goldcrest also participates in larger rounds such as Peregrine Technologies' $250M Series D at a $6.8B valuation and Sage Health's $65M Series C led by Goldman Sachs Alternatives, suggesting meaningful reserve capacity for follow-on within a focused portfolio.

As a venture capital vehicle, Goldcrest generates returns through equity ownership and, by industry convention, earns management fees on committed capital plus carried interest on realizations. The firm markets itself through a corporate website (goldcrest.com), an investor portal hosted on fundpanel.io, and a brand assets portal for portfolio companies and press. No AUM, fund vintage, or revenue figures are disclosed, and the provided financial dataset contains figures that are implausible for a sponsor of this size and are not relied upon in this analysis.

Goldcrest Capital firmographics

Firmographics
Name
Goldcrest Capital
Legal name
Goldcrest Capital
Website
https://goldcrest.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
1–10 employees
Short description
Goldcrest Capital is a Dallas-based venture capital fund founded in 2016 that invests in private technology companies across AI, healthcare, biotech, cybersecurity, insurtech, and energy, deploying capital from seed through Series D as lead, co-lead, and participating investor.
Ownership category
akta.pro rank

Goldcrest Capital industry classification

Industry
Product category
Venture Capital
NAICS
Other Investment Pools and Funds (5259), Other Financial Vehicles (525990)
SIC
Investment Advice (6282)
akta.pro primary industry
Late-Stage Venture Capital (Series C+) (FSANAAAC)

Keywords

  • Venture capital
  • Private equity investing
  • Growth capital
  • Technology investments
  • Early-stage funding

Where Goldcrest Capital is headquartered

Location

Headquarters

HQ city
Dallas
HQ country
United States
HQ region
North America

Markets served

Goldcrest Capital business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Distribution channels1 record

Marketing channels3 records

Goldcrest Capital product offering

Product offering

Core offering

Goldcrest Capital is a venture capital fund that invests in private technology companies across multiple stages from seed to Series D. The firm provides equity capital, strategic guidance, and network access to portfolio companies, participating as both lead and co-investor in funding rounds alongside other VC firms. Investments span AI, healthcare technology, cybersecurity, biotechnology, and energy sectors.

Product overview

Goldcrest Capital is a venture capital fund that invests in private technology companies. As an investment firm, it does not offer products or services in the traditional sense. The company participates in funding rounds for technology startups across various sectors including AI, healthcare technology, cybersecurity, and enterprise software.

Differentiator

Problem solved

Functional benefit

Products and services

  • Goldcrest Capital Venture Fund Equity capital fund that invests in private technology companies across stages from seed to Series D, spanning sectors such as AI, healthcare technology, cybersecurity, biotechnology, and energy. Targets founders and management teams of private technology startups seeking growth and scaling capital.

Companies that use Goldcrest Capital

Customer profile

Segments1 record

Ideal customer profiles1 record

Goldcrest Capital technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Goldcrest Capital partnerships and signals

Strategic signal

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Goldcrest Capital competitors and assessment

Company assessment

Broad incumbents

  • IVP (Institutional Venture Partners): Co-invested with Goldcrest in Sage Health's $65M Series C; a much larger late-stage growth VC that Goldcrest partners with on follow-on rounds.
  • Craft Ventures: Co-investor alongside Goldcrest in Glue's Series A; a larger, more established early-stage SaaS and AI venture firm with broader portfolio and brand recognition.
  • New Enterprise Associates (NEA): Led QuoteWell's $12M round in which Goldcrest participated; a large multi-stage venture firm that signals deal-quality validation when co-investing with smaller funds like Goldcrest.

Direct peers

  • Leblon Capital: Referenced alongside Goldcrest as part of the same co-investor network; a comparable early-to-mid stage venture investor with similar technology focus.
  • Friends & Family Capital: Co-led Northslope's $22M Series A alongside Goldcrest Capital, indicating comparable stage, check size, and technology focus on applied AI and Palantir-ecosystem companies.
  • MHS Capital: Led Fencer's $5.5M seed round in which Goldcrest participated, making it a comparable early-stage cybersecurity investor with similar check sizes and stage focus.
  • Abstract Ventures: Led Glue's $20M Series A which Goldcrest joined; an early-stage venture firm investing across similar AI, SaaS, and frontier-tech categories with comparable check sizes.
  • Chapter One: Co-invested with Goldcrest in Glue's Series A; an early-stage tech-focused VC with comparable seed/Series A check sizes and horizontal technology mandate.
  • Godfrey Capital: Co-led Junevity's expanded $20M seed round with Goldcrest, indicating a similar early-stage biotech and technology investor profile with comparable check sizes.
  • Fifth Down Capital: Referenced as a co-investment partner alongside Goldcrest in the firm's marketing channels, suggesting a comparable early-stage technology VC with similar deal sourcing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Goldcrest Capital social profiles

Digital presence

Goldcrest Capital financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Goldcrest Capital leadership team

Management profile

Number of profiles

Profiles1 record

Goldcrest Capital funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Goldcrest Capital M&A and investment

M&A and investment

M&A

Investments76 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Goldcrest Capital

What does Goldcrest Capital do?

Goldcrest Capital is a venture capital fund that invests in private technology companies across multiple stages from seed to Series D. The firm provides equity capital, strategic guidance, and network access to portfolio companies, participating as both lead and co-investor in funding rounds alongside other VC firms. Investments span AI, healthcare technology, cybersecurity, biotechnology, and energy sectors.

Is Goldcrest Capital a public or private company?

Goldcrest Capital is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Goldcrest Capital founded?

Goldcrest Capital was founded in 2016. It employs 1 to 10 people.

Where is Goldcrest Capital based?

Goldcrest Capital is headquartered in Dallas, United States, in the North America region.

Who are Goldcrest Capital's main competitors?

Broad incumbents on record are IVP (Institutional Venture Partners), Craft Ventures and New Enterprise Associates (NEA). Direct peers are Leblon Capital, Friends & Family Capital, MHS Capital, Abstract Ventures, Chapter One, Godfrey Capital and Fifth Down Capital.

Does Goldcrest Capital have an API?

No public API is recorded for Goldcrest Capital.

What industry is Goldcrest Capital in?

Goldcrest Capital's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAC, Late-Stage Venture Capital (Series C+). Its NAICS code is 5259 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
pharmaphorumWhich biotechs have raised new VC financing this week?Vaderis Therapeutics raised $152 million in second-round financing to fund its phase 3 trial of engasertib for hereditary haemorrhagic telangiectasia. Aureka Biotechnologies closed a $100 million Series B, Epicrispr raised $90 million, Infinimmune added $75 million, and Boulevard Bio emerged with $65 million.Venture Capital Access OnlineInfinimmune Raises $75 Million Series A Financing to Advance Pipeline of Human-Derived Antibodies for Atopic Dermatitis and Inflammatory DiseaseInfinimmune closed a $75 million Series A co-led by Regeneron Ventures and Playground Global. The funds will accelerate clinical development of two lead antibodies for atopic dermatitis, with first-in-human studies starting in 2027. The company also entered a Merck collaboration in March 2026.SynBioBetaRe-engineering immune memory for tissue repairInfinimmune raised $75 million in Series A funding to advance its human-derived monoclonal antibodies toward clinical trials. The capital supports first-in-human trials for two atopic dermatitis candidates in 2027, targeting IL-13 and IL-22. The company may later apply its platform to age-related immune decline.The SaaS NewsPeregrine Technologies Raises $250M Series DPeregrine Technologies, a San Francisco-based AI platform provider, announced a $250 million Series D financing round, valuing the company at $6.8 billion. The funding was co-led by Fifth Down Capital, Sequoia Capital, OG Venture Partners, Goldcrest Capital, XYZ Ventures, and Godfrey Capital, with proceeds earmarked for product development, engineering team expansion, and international market growth. The company, founded in 2018, offers a full-stack AI platform designed to unify fragmented operational data for government and enterprise clients.FinSMEsPeregrine Technologies Raises $250M in Series D Funding, at $6.8 Billion ValuationPeregrine Technologies raised $250M in Series D funding at a $6.8 billion valuation, led by existing investors. The company will use the funds for product development, team expansion, international growth, and employee liquidity. The AI platform has been used for major events and public safety operations.Venture Capital Access OnlinePeregrine Technologies Raises $250 Million Series D at $6.8 Billion ValuationPeregrine Technologies raised $250 million in a Series D at a $6.8 billion valuation, led by existing investors. The company has doubled its customer base to over 400 agencies and is expanding into federal, enterprise, and international markets. The financing will support product development, team growth, and a liquidity opportunity for employees.MorningstarPeregrine Technologies Raises $250 Million Series D at $6.8 Billion ValuationPeregrine Technologies raised $250 million in Series D financing at a $6.8 billion valuation, led by existing investors. The company has doubled its customer base to over 400 agencies and is expanding into federal, enterprise, and international markets. The funds will support product development, team expansion, and a liquidity opportunity for employees.VC News DailySage Raises $65M in Series C FundingSage Health has closed a $65 million Series C funding round, with Goldman Sachs leading the investment and continued support from existing investors IVP and Goldcrest. The funding round, conducted in New York, represents a significant capital injection for the healthcare company. The raise comes at a time when venture capital investment in health tech continues to flow, though no specific use of proceeds was detailed.ForbesHow A Lifetime Of Learning Has Transformed The Vintage Car ‘Restomod’ BusinessKindred Motorworks, a San Francisco-based vintage car restoration company founded by CEO Rob Howard in 2019, has developed a tech-focused approach to restomodding classic vehicles like the Ford Bronco, Volkswagen Bus, and Chevrolet Camaro, offering both ICE and EV powertrains. The company has raised over $50 million from investors including Fifth Down Capital, CPMG, Goldcrest, Lunch Pail Ventures, Helium 3, and Robert Downey Jr., and operates from a 100,000 square foot production facility producing approximately two vehicles per week at price points around $200,000 each. Kindred employs around 110 workers and uses proprietary technology to standardize the 5,000-step restoration process, reportedly reducing restoration time to less than half that of traditional auto shops.ForbesHow A Lifetime Of Learning Has Transformed The Vintage Car ‘Restomod’ BusinessKindred Motorworks, a San Francisco-based company founded in 2019 by CEO Rob Howard, has developed a tech-focused approach to restoring and modifying vintage cars including the Ford Bronco, Volkswagen Bus, and Chevrolet Camaro, offering both traditional internal combustion and EV powertrains. The company has raised over $50 million from investors including Fifth Down Capital, CPMG, Goldcrest, Lunch Pail Ventures, Helium 3, and Robert Downey Jr., operates from a 100,000 square foot production facility, and produces approximately two vehicles per week at around $200,000 each. Kindred uses proprietary technology to track 5,000 restoration steps and deliver parts to workers in real time, enabling scalable restoration and EV conversion of vintage vehicles.